{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:48Z","timestamp":1772119308283,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-023-03028-7","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T03:02:34Z","timestamp":1690772554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of palliative surgery for gastric cancer patients with peritoneal metastasis who still have residual peritoneal dissemination after chemotherapy"],"prefix":"10.1007","volume":"408","author":[{"given":"Masayuki","family":"Shinkai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Imano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kohda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaomi","family":"Hagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Tsubaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takushi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"3028_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegal RI et al (2021) Global cancer statistics 2020: GLOBACAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"3028_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s00535-008-2177-6","volume":"43","author":"A Ohtsu","year":"2008","unstructured":"Ohtsu A (2008) Chemotherapy for metastatic gastric cancer: past, present, and future. J Gastroenterol 43:256\u2013264","journal-title":"J Gastroenterol"},{"key":"3028_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000218355","volume":"32","author":"D Gencer","year":"2009","unstructured":"Gencer D, Kastle-Larralde N, Pilz LR et al (2009) Presentation, treatment, and analysis of prognostic factors of terminally ill patients with gastrointestinal tumors. Onkologie 32:380\u2013386","journal-title":"Onkologie"},{"key":"3028_CR4","first-page":"CD004064","volume":"8","author":"AD Wagner","year":"2017","unstructured":"Wagner AD, Syn NL, Moehler M et al (2017) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 8:CD004064","journal-title":"Cochrane Database Syst Rev"},{"key":"3028_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10120-018-0838-6","volume":"22","author":"A Takashima","year":"2019","unstructured":"Takashima A, Shitara K, Fujitani K et al (2019) Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial. Gastric Cancer 22:155\u2013163","journal-title":"Gastric Cancer"},{"key":"3028_CR6","first-page":"7037","volume":"37","author":"T Masuishi","year":"2017","unstructured":"Masuishi T, Kadowaki S, Kondo M et al (2017) FOLFOX as first-line therapy for gastric cancer with severe peritoneal metastasis. Anticancer Res 37:7037\u20137042","journal-title":"Anticancer Res"},{"key":"3028_CR7","first-page":"4071","volume":"32","author":"M Imano","year":"2012","unstructured":"Imano M, Peng YF, Itoh T et al (2012) A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis. Anticancer Res 32:4071\u20134076","journal-title":"Anticancer Res"},{"key":"3028_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10120-015-0575-z","volume":"19","author":"K Yoshida","year":"2016","unstructured":"Yoshida K, Yamaguchi K, Okumura N et al (2016) Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer 19:329\u2013338","journal-title":"Gastric Cancer"},{"key":"3028_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10120-017-0738-1","volume":"21","author":"K Yamaguchi","year":"2018","unstructured":"Yamaguchi K, Yoshida K, Tanahashi T et al (2018) The long-term survival of stage IV gastric cancer patients with conversion therapy. Gastric Cancer 21:315\u2013323","journal-title":"Gastric Cancer"},{"key":"3028_CR10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00423-021-02410-7","volume":"407","author":"M Shinkai","year":"2022","unstructured":"Shinkai M, Imano M, Hiraki Y et al (2022) Efficacy of conversion surgery after a single intraperitoneal administration of paclitaxel and systemic chemotherapy for gastric cancer with peritoneal metastasis. Langenbeck's Arch Surg 407:975\u2013983","journal-title":"Langenbeck's Arch Surg"},{"key":"3028_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauser","year":"2009","unstructured":"Eisenhauser EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"3028_CR12","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s11605-012-2059-3","volume":"16","author":"M Imano","year":"2012","unstructured":"Imano M, Peng YF, Itoh T et al (2012) Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis. J Gastrointest Surg 16:2190\u20132196","journal-title":"J Gastrointest Surg"},{"key":"3028_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demarines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"3028_CR14","volume-title":"Japanese classification of gastric carcinoma","author":"Japanese Research Society for Gastric Cancer","year":"1995","unstructured":"Japanese Research Society for Gastric Cancer (1995) Japanese classification of gastric carcinoma, 1st edn. Kanehara & Co., Ltd, Tokyo","edition":"1"},{"key":"3028_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Japanese Gastric Cancer Association","year":"2011","unstructured":"Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101\u2013112","journal-title":"Gastric Cancer"},{"key":"3028_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00595-022-02567-8","volume":"53","author":"S Yang","year":"2023","unstructured":"Yang S, Ida S, Namikawa K et al (2023) Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer. Surg Today 53:360\u2013368","journal-title":"Surg Today"},{"key":"3028_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12885-021-07904-7","volume":"21","author":"XJ Chen","year":"2021","unstructured":"Chen XJ, Chen GM, Wei YC et al (2021) Palliative gastrectomy versus gastrojejunostomy for advanced gastric cancer with outlet obstruction: a propensity score matching analysis. BMC Cancer 21:188","journal-title":"BMC Cancer"},{"key":"3028_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/medicina57030198","volume":"57","author":"JY Park","year":"2021","unstructured":"Park JY, Yu B, Park KB et al (2021) Impact of palliative gastrectomy in patients with incurable gastric cancer. Medicina 57:198","journal-title":"Medicina"},{"key":"3028_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00268-018-4816-2","volume":"43","author":"H Omori","year":"2019","unstructured":"Omori H, Tanizawa Y, Makuuchi R et al (2019) Role of palliative resection in patients with incurable advanced gastric cancer who are unfit for chemotherapy. World J Surg 43:571\u2013579","journal-title":"World J Surg"},{"key":"3028_CR20","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.21873\/anticanres.13376","volume":"39","author":"D Matsubara","year":"2019","unstructured":"Matsubara D, Konishi H, Kubota T et al (2019) Comparison of clinical outcomes of gastrojejunal bypass and gastrectomy in patients with metastatic gastric cancer. Anticancer Res 39:2543\u20132551","journal-title":"Anticancer Res"},{"key":"3028_CR21","first-page":"2079","volume":"397","author":"K Lasithiotakis","year":"2014","unstructured":"Lasithiotakis K, Antoniou SA, Antoniou GA et al (2014) Gastrectomy for stage IV gastric cancer: a systemic review and meta-analysis. Anticancer Res 397:2079\u20132085","journal-title":"Anticancer Res"},{"key":"3028_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11605-013-2415-y","volume":"18","author":"A Collins","year":"2014","unstructured":"Collins A, Hatzaras I, Schmidt C et al (2014) Gastrectomy in advanced gastric cancer effectively palliates symptoms and may improves survival in select patients. J Gastrointest Surg 18:491\u2013496","journal-title":"J Gastrointest Surg"},{"key":"3028_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s00268-015-3398-5","volume":"40","author":"M Tokunaga","year":"2016","unstructured":"Tokunaga M, Makuuchi R, Miki Y et al (2016) Surgical and survival outcome following truly palliative gastrectomy in patients with incurable gastric cancer. World J Surg 40:1172\u20131177","journal-title":"World J Surg"},{"key":"3028_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s10120-020-01114-z","volume":"24","author":"M Terashima","year":"2021","unstructured":"Terashima M, Fujitani K, Ando M et al (2021) Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by incurable advanced gastric cancer. Gastric Cancer 24:224\u2013231","journal-title":"Gastric Cancer"},{"key":"3028_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s10120-021-01251-z","volume":"25","author":"R Kawabata","year":"2022","unstructured":"Kawabata R, Fujitani K, Sakamoto K et al (2022) Survival analysis of a prospective multicenter observation study on survival palliation among patients with malignant bowel obstruction caused by peritoneal dissemination of gastric cancer. Gastric Cancer 25:422\u2013429","journal-title":"Gastric Cancer"},{"key":"3028_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arend","year":"2017","unstructured":"Arend J, Bachmann P, Baracos V et al (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36:11\u201348","journal-title":"Clin Nutr"},{"key":"3028_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","volume":"17","author":"K Fujitani","year":"2016","unstructured":"Fujitani K, Yang HK, Mizusawa J et al (2016) Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3. Randomized controlled trial. Lancet Oncol 17:309\u2013318","journal-title":"Randomized controlled trial Lancet Oncol"},{"key":"3028_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-020-01042-y","volume":"24","author":"Japanese Gastric Cancer Association","year":"2021","unstructured":"Japanese Gastric Cancer Association (2021) Japanese gastric cancer treatment guideline 2018, 5th edn. Gastric Cancer 24:1\u201321","journal-title":"Gastric Cancer"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-023-03028-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T19:09:17Z","timestamp":1705604957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-023-03028-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1007\/s00423-023-03028-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3028291\/v1","asserted-by":"object"}]},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted in accordance with the ethical standards of the committee on human experimentation and with the Helsinki Declaration of 1964 and later versions. This study was approved by the institutional review board of the Kindai University Faculty of Medicine (approval No. 31-085).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent or substitute consent was obtained from all patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"291"}}